Shuhang Wang

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel

Zhijie Wang, Jianchun Duan, Shangli Cai et al. · JAMA Oncology · 2019 · 495 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients

Xiaohui Ni, Minglei Zhuo, Zhe Su et al. · Proceedings of the National Academy of Sciences · 2013 · 481 citations · Full text

Medicine, Genetics, Oncology +17

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

Shugeng Gao, Ning Li, Shun‐Yu Gao et al. · Journal of Thoracic Oncology · 2020 · 415 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer

Jiefei Han, Jianchun Duan, Hua Bai et al. · Cancer Immunology Research · 2019 · 277 citations

Medicine, Immunology, Oncology +17

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

Zhijie Wang, Jing Zhao, Guoqiang Wang et al. · Cancer Research · 2018 · 261 citations

Life Sciences, Immunology, Oncology +17